INSP
Inspire Medical Systems Inc

1,573
Mkt Cap
$2.22B
Volume
994,365.00
52W High
$216.01
52W Low
$70.77
PE Ratio
43.55
INSP Fundamentals
Price
$73.07
Prev Close
$75.17
Open
$75.17
50D MA
$81.58
Beta
1.10
Avg. Volume
1.1M
EPS (Annual)
$1.75
P/B
3.28
Rev/Employee
$644,304.98
Loading...
Loading...
News
all
press releases
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2d ago
News Placeholder
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
Zacks·18d ago
News Placeholder
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
Zacks·29d ago
News Placeholder
Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·2mo ago
News Placeholder
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Zacks·2mo ago
News Placeholder
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Zacks·3mo ago
News Placeholder
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversold
Truist said it was braced for a guidance cut, but it was bigger than expected, and a lower earnings per share outlook reduces the stock valuation floor.
Stocktwits·3mo ago
News Placeholder
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
Zacks·3mo ago
News Placeholder
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·3mo ago

Latest INSP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.